443 related articles for article (PubMed ID: 23938455)
1. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.
Taly V; Pekin D; Benhaim L; Kotsopoulos SK; Le Corre D; Li X; Atochin I; Link DR; Griffiths AD; Pallier K; Blons H; Bouché O; Landi B; Hutchison JB; Laurent-Puig P
Clin Chem; 2013 Dec; 59(12):1722-31. PubMed ID: 23938455
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy.
Laurent-Puig P; Pekin D; Normand C; Kotsopoulos SK; Nizard P; Perez-Toralla K; Rowell R; Olson J; Srinivasan P; Le Corre D; Hor T; El Harrak Z; Li X; Link DR; Bouché O; Emile JF; Landi B; Boige V; Hutchison JB; Taly V
Clin Cancer Res; 2015 Mar; 21(5):1087-97. PubMed ID: 25248381
[TBL] [Abstract][Full Text] [Related]
3. Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer.
Yokota T; Shibata N; Ura T; Takahari D; Shitara K; Muro K; Yatabe Y
Transl Res; 2010 Aug; 156(2):98-105. PubMed ID: 20627194
[TBL] [Abstract][Full Text] [Related]
4. The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer.
Mancini I; Santucci C; Sestini R; Simi L; Pratesi N; Cianchi F; Valanzano R; Pinzani P; Orlando C
J Mol Diagn; 2010 Sep; 12(5):705-11. PubMed ID: 20616366
[TBL] [Abstract][Full Text] [Related]
5. Surface Enhanced Raman Spectroscopy (SERS) for the Multiplex Detection of Braf, Kras, and Pik3ca Mutations in Plasma of Colorectal Cancer Patients.
Li X; Yang T; Li CS; Song Y; Lou H; Guan D; Jin L
Theranostics; 2018; 8(6):1678-1689. PubMed ID: 29556349
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.
Gasch C; Bauernhofer T; Pichler M; Langer-Freitag S; Reeh M; Seifert AM; Mauermann O; Izbicki JR; Pantel K; Riethdorf S
Clin Chem; 2013 Jan; 59(1):252-60. PubMed ID: 23136247
[TBL] [Abstract][Full Text] [Related]
7. Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer.
Brychta N; Krahn T; von Ahsen O
Clin Chem; 2016 Nov; 62(11):1482-1491. PubMed ID: 27591291
[TBL] [Abstract][Full Text] [Related]
8. Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.
Lamy PJ; Castan F; Lozano N; Montélion C; Audran P; Bibeau F; Roques S; Montels F; Laberenne AC
J Mol Diagn; 2015 Jul; 17(4):366-73. PubMed ID: 25952101
[TBL] [Abstract][Full Text] [Related]
9. Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients.
Hosoya K; Matsusaka S; Kashiwada T; Suzuki K; Ureshino N; Sato A; Miki Y; Kitera K; Hirai M; Hatake K; Kimura S; Sueoka-Aragane N
Pathol Oncol Res; 2017 Oct; 23(4):737-744. PubMed ID: 28058585
[TBL] [Abstract][Full Text] [Related]
10. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
[TBL] [Abstract][Full Text] [Related]
11. KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients.
Olmedillas López S; García-Olmo DC; García-Arranz M; Guadalajara H; Pastor C; García-Olmo D
Int J Mol Sci; 2016 Apr; 17(4):484. PubMed ID: 27043547
[TBL] [Abstract][Full Text] [Related]
12. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.
Mostert B; Jiang Y; Sieuwerts AM; Wang H; Bolt-de Vries J; Biermann K; Kraan J; Lalmahomed Z; van Galen A; de Weerd V; van der Spoel P; Ramírez-Moreno R; Verhoef C; Ijzermans JN; Wang Y; Gratama JW; Foekens JA; Sleijfer S; Martens JW
Int J Cancer; 2013 Jul; 133(1):130-41. PubMed ID: 23233388
[TBL] [Abstract][Full Text] [Related]
13. Multiplex detection of KRAS mutations by a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay.
Choi HS; Min KT; Cha YS; Hong SP
Clin Biochem; 2014 Aug; 47(12):1091-7. PubMed ID: 24726492
[TBL] [Abstract][Full Text] [Related]
14. Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer.
Kuo YB; Chen JS; Fan CW; Li YS; Chan EC
Clin Chim Acta; 2014 Jun; 433():284-9. PubMed ID: 24685572
[TBL] [Abstract][Full Text] [Related]
15. KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.
Xu JM; Liu XJ; Ge FJ; Lin L; Wang Y; Sharma MR; Liu ZY; Tommasi S; Paradiso A
J Exp Clin Cancer Res; 2014 Dec; 33(1):104. PubMed ID: 25491325
[TBL] [Abstract][Full Text] [Related]
16. Direct circulating tumor DNA detection from unpurified plasma using a digital PCR platform.
Sefrioui D; Beaussire L; Perdrix A; Clatot F; Michel P; Frebourg T; Di Fiore F; Sarafan-Vasseur N
Clin Biochem; 2017 Nov; 50(16-17):963-966. PubMed ID: 28645720
[TBL] [Abstract][Full Text] [Related]
17. Screening for circulating RAS/RAF mutations by multiplex digital PCR.
Andersen RF; Jakobsen A
Clin Chim Acta; 2016 Jul; 458():138-43. PubMed ID: 27181912
[TBL] [Abstract][Full Text] [Related]
18. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E
J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527
[TBL] [Abstract][Full Text] [Related]
19. Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.
Decraene C; Silveira AB; Bidard FC; Vallée A; Michel M; Melaabi S; Vincent-Salomon A; Saliou A; Houy A; Milder M; Lantz O; Ychou M; Denis MG; Pierga JY; Stern MH; Proudhon C
Clin Chem; 2018 Feb; 64(2):317-328. PubMed ID: 29122835
[TBL] [Abstract][Full Text] [Related]
20. Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene.
Mariani S; Bertero L; Osella-Abate S; Di Bello C; Francia di Celle P; Coppola V; Sapino A; Cassoni P; Marchiò C
Br J Cancer; 2017 Jul; 117(3):358-366. PubMed ID: 28618430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
